Does Circadian Misalignment Have Sex-Specific Effects on Metabolism?

February 23, 2026 updated by: Jingyi Qian, Brigham and Women's Hospital

Role of Biological Sex in Metabolic Responses to Night Work

This study will test whether biological sex influences how the body responds to circadian misalignment-a mismatch between the internal body clock and the timing of sleep and eating (as can occur with shift work or jet lag). Researchers will examine how circadian misalignment affects appetite regulation (hunger/fullness) and glucose metabolism (blood sugar control), and whether these effects differ between females and males. Findings may help inform more personalized shift work schedules and targeted strategies to reduce metabolic health risks and sex-related differences in clinical care.

Study Overview

Status

Not yet recruiting

Detailed Description

This study will examine whether biological sex affects how the body responds to circadian misalignment-a mismatch between a person's internal body clock and their sleep/wake and eating schedule (similar to what can happen with night shift work, jet lag, or frequently changing sleep schedules). Researchers will measure how circadian misalignment influences appetite regulation (such as hunger and fullness) and glucose metabolism (how the body controls blood sugar), and whether these effects differ between females and males.

By identifying sex-specific responses to circadian misalignment, this research may help guide the development of safer, more personalized shift work schedules and targeted strategies to reduce metabolic health risks, with the goal of improving clinical care and reducing sex-related differences in metabolic disease risk.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jingyi Qian, PhD
  • Phone Number: 617-525-7423
  • Email: jqian5@mgb.org

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-40 years of age
  • Body Mass Index 18.5-24.9 kg/m2
  • Non-smokers, no current tobacco or e-cigarette use
  • Healthy with no acute or chronic medical and psychiatric disorders
  • Sex assigned at birth consistent with reproductive anatomy at enrollment (per protocol definition)

Exclusion Criteria:

  • History of drug or alcohol dependency
  • History of psychiatric illness or disorder
  • Pregnant
  • No prior gender-affirming hormone therapy and no gonadectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Day Shift -> Night Shift
Day Shift protocol first, then Night Shift protocol
Research participants will be assigned to day shift condition in which sleep-wake and meal schedules are aligned with the internal circadian system
Research participants will be assigned to simulated night shift condition in which sleep-wake and meal schedules are misaligned with the internal circadian system
Experimental: Night shift -> Day shift
Night shift protocol first, then Day Shift protocol
Research participants will be assigned to day shift condition in which sleep-wake and meal schedules are aligned with the internal circadian system
Research participants will be assigned to simulated night shift condition in which sleep-wake and meal schedules are misaligned with the internal circadian system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in circulating leptin levels between Night Shift and Day Shift
Time Frame: 24 hours
Differences of 24-h circulating leptin levels on the test days in the two experimental conditions
24 hours
Differences in Disposition index (DI) derived from identical test breakfast between Night Shift and Day Shift
Time Frame: 3 hours
Disposition index (DI) derived from oral minimal model based on postprandial glucose, insulin, and c-peptide responses to identical test breakfast on the test days between protocols
3 hours
Differences in self-rated cravings for hyperpalatable food during the wake period between Night Shift and Day Shift.
Time Frame: 16 hours
Differences in self-rated cravings for hyperpalatable food during the wake period on the test days between protocols.
16 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jingyi Qian, PhD, Brigham and Women's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

September 30, 2030

Study Completion (Estimated)

September 30, 2030

Study Registration Dates

First Submitted

February 23, 2026

First Submitted That Met QC Criteria

February 23, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 23, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sex Differences

Clinical Trials on Day shift

Subscribe